136 related articles for article (PubMed ID: 17537644)
1. FGF2 effects in periosteal fibroblasts bearing the FGFR2 receptor Pro253 Arg mutation.
Lilli C; Bellucci C; Baroni T; Aisa C; Carinci P; Scapoli L; Carinci F; Pezzetti F; Lumare E; Stabellini G; Bodo M
Cytokine; 2007 Apr; 38(1):22-31. PubMed ID: 17537644
[TBL] [Abstract][Full Text] [Related]
2. Basic fibroblast growth factor: effects on matrix remodeling, receptor expression, and transduction pathway in human periosteal fibroblasts with FGFR2 gene mutation.
Bodo M; Lilli C; Aisa MC; Scapoli L; Bellucci C; Rinaldi E; Tosi L; Baroni T; Conte C; Bellocchio S; Carinci F; Stabellini G; Carinci P
J Interferon Cytokine Res; 2002 Jun; 22(6):621-30. PubMed ID: 12162872
[TBL] [Abstract][Full Text] [Related]
3. Role of the extracellular matrix and growth factors in skull morphogenesis and in the pathogenesis of craniosynostosis.
Carinci P; Becchetti E; Bodo M
Int J Dev Biol; 2000; 44(6):715-23. PubMed ID: 11061436
[TBL] [Abstract][Full Text] [Related]
4. P253R fibroblast growth factor receptor-2 mutation induces RUNX2 transcript variants and calvarial osteoblast differentiation.
Baroni T; Carinci P; Lilli C; Bellucci C; Aisa MC; Scapoli L; Volinia S; Carinci F; Pezzetti F; Calvitti M; Farina A; Conte C; Bodo M
J Cell Physiol; 2005 Feb; 202(2):524-35. PubMed ID: 15389579
[TBL] [Abstract][Full Text] [Related]
5. Negative autoregulation of fibroblast growth factor receptor 2 expression characterizing cranial development in cases of Apert (P253R mutation) and Pfeiffer (C278F mutation) syndromes and suggesting a basis for differences in their cranial phenotypes.
Britto JA; Moore RL; Evans RD; Hayward RD; Jones BM
J Neurosurg; 2001 Oct; 95(4):660-73. PubMed ID: 11596961
[TBL] [Abstract][Full Text] [Related]
6. A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis.
Yin L; Du X; Li C; Xu X; Chen Z; Su N; Zhao L; Qi H; Li F; Xue J; Yang J; Jin M; Deng C; Chen L
Bone; 2008 Apr; 42(4):631-43. PubMed ID: 18242159
[TBL] [Abstract][Full Text] [Related]
7. Novel molecular pathways elicited by mutant FGFR2 may account for brain abnormalities in Apert syndrome.
Yeh E; Fanganiello RD; Sunaga DY; Zhou X; Holmes G; Rocha KM; Alonso N; Matushita H; Wang Y; Jabs EW; Passos-Bueno MR
PLoS One; 2013; 8(4):e60439. PubMed ID: 23593218
[TBL] [Abstract][Full Text] [Related]
8. Expression profiles of craniosynostosis-derived fibroblasts.
Carinci F; Bodo M; Tosi L; Francioso F; Evangelisti R; Pezzetti F; Scapoli L; Martinelli M; Baroni T; Stabellini G; Carinci P; Bellucci C; Lilli C; Volinia S
Mol Med; 2002 Oct; 8(10):638-44. PubMed ID: 12477974
[TBL] [Abstract][Full Text] [Related]
9. Dura in the pathogenesis of syndromic craniosynostosis: fibroblast growth factor receptor 2 mutations in dural cells promote osteogenic proliferation and differentiation of osteoblasts.
Ang BU; Spivak RM; Nah HD; Kirschner RE
J Craniofac Surg; 2010 Mar; 21(2):462-7. PubMed ID: 20489451
[TBL] [Abstract][Full Text] [Related]
10. Apert p.Ser252Trp mutation in FGFR2 alters osteogenic potential and gene expression of cranial periosteal cells.
Fanganiello RD; Sertié AL; Reis EM; Yeh E; Oliveira NA; Bueno DF; Kerkis I; Alonso N; Cavalheiro S; Matsushita H; Freitas R; Verjovski-Almeida S; Passos-Bueno MR
Mol Med; 2007; 13(7-8):422-42. PubMed ID: 17622301
[TBL] [Abstract][Full Text] [Related]
11. Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand.
Anderson J; Burns HD; Enriquez-Harris P; Wilkie AO; Heath JK
Hum Mol Genet; 1998 Sep; 7(9):1475-83. PubMed ID: 9700203
[TBL] [Abstract][Full Text] [Related]
12. Sequence analysis of fibroblast growth factor receptor 2 ( FGFR2 ) in Japanese patients with craniosynostosis.
Sakai N; Tokunaga K; Yamazaki Y; Shida H; Sakata Y; Susami T; Nakakita N; Takato T; Uchinuma E
J Craniofac Surg; 2001 Nov; 12(6):580-5. PubMed ID: 11711827
[TBL] [Abstract][Full Text] [Related]
13. Apert and Crouzon syndromes: clinical findings, genes and extracellular matrix.
Carinci F; Pezzetti F; Locci P; Becchetti E; Carls F; Avantaggiato A; Becchetti A; Carinci P; Baroni T; Bodo M
J Craniofac Surg; 2005 May; 16(3):361-8. PubMed ID: 15915098
[TBL] [Abstract][Full Text] [Related]
14. Clinicogenetic study of Turkish patients with syndromic craniosynostosis and literature review.
Nur BG; Pehlivanoğlu S; Mıhçı E; Calışkan M; Demir D; Alper OM; Kayserili H; Lüleci G
Pediatr Neurol; 2014 May; 50(5):482-90. PubMed ID: 24656465
[TBL] [Abstract][Full Text] [Related]
15. A regulatory role of fibroblast growth factor in the expression of decorin, biglycan, betaglycan and syndecan in osteoblasts from patients with Crouzon's syndrome.
Bodo M; Baroni T; Carinci F; Becchetti E; Bellucci C; Conte C; Pezzetti F; Evangelisti R; Tognon M; Carinci P
Eur J Cell Biol; 1999 May; 78(5):323-30. PubMed ID: 10384983
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of a novel FGFR2 mutation, E731K, in craniosynostosis.
Park J; Park OJ; Yoon WJ; Kim HJ; Choi KY; Cho TJ; Ryoo HM
J Cell Biochem; 2012 Feb; 113(2):457-64. PubMed ID: 21928350
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effect of nanogel-based delivery of soluble FGFR2 with S252W mutation on craniosynostosis.
Yokota M; Kobayashi Y; Morita J; Suzuki H; Hashimoto Y; Sasaki Y; Akiyoshi K; Moriyama K
PLoS One; 2014; 9(7):e101693. PubMed ID: 25003957
[TBL] [Abstract][Full Text] [Related]
18. Crouzon's syndrome: differential in vitro secretion of bFGF, TGFbeta I isoforms and extracellular matrix macromolecules in patients with FGFR2 gene mutation.
Baroni T; Lilli C; Marinucci L; Bellocchio S; Pezzetti F; Carinci F; Stabellini G; Balducci C; Locci P
Cytokine; 2002 Jul; 19(2):94-101. PubMed ID: 12182844
[TBL] [Abstract][Full Text] [Related]
19. Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses.
Passos-Bueno MR; Sertié AL; Richieri-Costa A; Alonso LG; Zatz M; Alonso N; Brunoni D; Ribeiro SF
Am J Med Genet; 1998 Jul; 78(3):237-41. PubMed ID: 9677057
[TBL] [Abstract][Full Text] [Related]
20. FGFR2 mutations among Thai children with Crouzon and Apert syndromes.
Shotelersuk V; Mahatumarat C; Ittiwut C; Rojvachiranonda N; Srivuthana S; Wacharasindhu S; Tongkobpetch S
J Craniofac Surg; 2003 Jan; 14(1):101-4; discussion 105-7. PubMed ID: 12544231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
